Amine derivatives

Details for Australian Patent Application No. 2004295032 (hide)

Owner Merck Patent GmbH

Inventors Holzemann, Gunter; Schiemann, Kai; Rautenberg, Wilfried

Agent Davies Collison Cave

Pub. Number AU-B-2004295032

PCT Pub. Number WO2005/054246

Priority 103 56 579.5 04.12.03 DE

Filing date 5 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 25 November 2010

International Classifications

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 249/14 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/054246 Priority application(s): WO2005/054246

25 November 2010 Application Accepted

  Published as AU-B-2004295032

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295036-Benzofurans and benzothiophenes

2004295029-Antidiabetic compounds comprising benzofuran and benzothiophene derivatives